AuntMinnieEurope.com staff writersClinical NewsSpanish group gives update on breast cancer risk prediction modelSpanish researchers have developed a breast cancer risk prediction model that they hope will make screening programs more effective.November 15, 2022Clinical NewsGerman group vows to ask: How fair are scientific awards?Researchers from Heinrich Heine University in Düsseldorf are launching a study to examine precisely how fair awards are in medicine and science.November 13, 2022Molecular ImagingReuters: Siemens seeks huge cost savings by restructuringSiemens Healthineers said it plans to restructure its diagnostics division to save about $302 million (292 million euros) each year starting in 2025, according to a Reuters report.November 13, 2022Artificial IntelligenceDensitas to highlight quality improvement studies at RSNABreast imaging software developer Densitas plans to highlight three quality improvement papers to be presented at the upcoming RSNA meeting that validate its intelliMammo artificial intelligence (AI) software.November 13, 2022Artificial IntelligenceAI study wins RSNA's Margulis AwardThe RSNA has bestowed its 2022 Alexander R. Margulis Award for Scientific Excellence on an artificial intelligence (AI) study that shows how an algorithm can improve the detection of trauma fractures on x-ray.November 13, 2022Clinical NewsSpanish radiology groups present annual awardsThe Spanish Society of Medical Radiology and the Spanish Radiology Foundation have handed out their 2022 awards.November 10, 2022Clinical NewsESR achieves new high on membership numbersThe European Society of Radiology (ESR) is highlighting the new all-time high in its membership count achieved in 2022.November 10, 2022Artificial IntelligenceBrainomix and Visionable partner on stroke careClinical collaboration platform Visionable and artificial intelligence (AI) company Brainomix are working together to co-market their respective software products for stroke care delivery.November 10, 2022Molecular ImagingBlue Earth moves toward U.K. prostate radiopharmaceutical licensingBlue Earth Therapeutics has secured an "innovation passport" from the U.K.'s Innovative Licensing and Access Pathway for its investigational therapeutic radiopharmaceutical lutetium-177 rhPSMA-10.1 for treatment of metastatic prostate cancer.November 8, 2022Industry NewsESR celebrates 11th International Day of RadiologyThe European Society of Radiology (ESR) and imaging professionals from around the world are celebrating the 11th International Day of Radiology.November 7, 2022Previous PagePage 119 of 952Next PageTop StoriesMolecular ImagingUnfilled vacancies and disparities persist in nuclear medicineNuclear medicine specialists have high career satisfaction, but unfilled vacancies and career disparities persist, finds a workforce survey by the European Association of Nuclear Medicine (EANM).Molecular ImagingPET develops key clinical role in neuroendocrine tumorsMolecular ImagingPET/CT visualizes complications in patients on hemodialysisCTAll roads lead to outsourcingMRIZonal segmentation with AI shows promise in prostate cancer
